Title of Collaborative Activity: |
Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A |
Description of Collaborative Activity: |
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new non-animal-based assays to assess the potency of botulinum neurotoxin type A (BoNT/A) in a Good Manufacturing Practice (GMP) commercial environment. (STTR [R41/R42]) [PA-09-178], (SBIR [R43/R44]) [PA-09-179]. |
Type of Collaborative Activity: |
Select Type of Collaborative Activity
|
Year the Collaborative Activity Originated: |
2010 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID, NINDS |
HHS Agency Collaborators on this Activity: |
FDA |
